Unknown

Dataset Information

Predicting patent challenges for small-molecule drugs: A cross-sectional study.


ABSTRACT:

Background

The high cost of prescription drugs in the United States is maintained by brand-name manufacturers' competition-free period made possible in part through patent protection, which generic competitors must challenge to enter the market early. Understanding the predictors of these challenges can inform policy development to encourage timely generic competition. Identifying categories of drugs systematically overlooked by challengers, such as those with low market size, highlights gaps where unchecked patent quality and high prices persist, and can help design policy interventions to help promote timely patient access to generic drugs including enhanced patent scrutiny or incentives for challenges. Our objective was to characterize and assess the extent to which market size

SUBMITTER: Memedovich A 

PROVIDER: S-EPMC11867330 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature